For malignant effusions associated with lung cancer, the diagnostic performance of CEA was better than HFC and cytokeratin 19 fragment (CYFRA21-1), but there was no significant difference between HFC and CYFRA21-1. The gene discussed is KRT19; the disease is lung cancer.